There is evidence that the cytotoxic tumor lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) immune checkpoints are highly expressed on the surface of T, B, and NK cells in the bone marrow of patients with MM [120,121]. This evidence concerns the gene PDCD1 and Miyoshi myopathy.